Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people …
S Pepin, JF Nicolas, H Szymanski… - Human Vaccines & …, 2021 - Taylor & Francis
ABSTRACT A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …
[PDF][PDF] Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy …
S Pepin, JF Nicolas, H Szymanski… - HUMAN VACCINES & …, 2021 - iris.unipa.it
ABSTRACT A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people …
S Pepin, JF Nicolas, H Szymanski… - Human vaccines & …, 2021 - pubmed.ncbi.nlm.nih.gov
A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for adults≥ 65
y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been …
y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been …
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people …
QHD00011 study team - Human Vaccines & …, 2021 - ingentaconnect.com
A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for adults≥ 65
y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been …
y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been …
[PDF][PDF] Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy …
S Pepin, JF Nicolas, H Szymanski… - HUMAN …, 2021 - backoffice.biblio.ugent.be
ABSTRACT A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …
[HTML][HTML] Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in …
S Pepin, JF Nicolas, H Szymanski… - Human Vaccines & …, 2021 - ncbi.nlm.nih.gov
ABSTRACT A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people …
S Pepin, JF Nicolas, H Szymanski… - Human Vaccines & …, 2021 - europepmc.org
ABSTRACT A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people …
S Pepin, JF Nicolas, H Szymanski… - HUMAN VACCINES …, 2021 - biblio.ugent.be
A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for adults>= 65
y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been …
y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been …
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people …
S Pepin, H Szymanski, I Leroux-Roels… - HUMAN VACCINES & …, 2021 - iris.unipa.it
A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for adults≥ 65
y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been …
y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been …
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people …
S Pepin, JF Nicolas, H Szymanski… - Human Vaccines & …, 2021 - europepmc.org
ABSTRACT A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …
adults≥ 65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has …